This inventor holds 3 USPTO granted patents. Top assignee: Other. Active years: 1984-1989.
Location History:
- Tel Hashomer, IL (1984)
- Kiryat Krinitzi, Ramat Gan, IL (1989)
Company Filing History:
3 out of 834,411 Years Active: 1984-1989
Title: Innovations by Raphael Mohr in Myocardial Ischemia Detection
Introduction
Raphael Mohr is an accomplished inventor based in Kiryat Krinitzi, Ramat Gan, Israel. He has made significant contributions to the field of medical technology, particularly in the detection of myocardial ischemia. With a total of 3 patents to his name, Mohr's work focuses on innovative methods and apparatuses that enhance patient care and monitoring.
Latest Patents
One of Mohr's latest patents is a method and apparatus for detecting myocardial ischemia. This invention monitors the systemic vascular resistance of a subject and identifies the presence of myocardial ischemia when there is a significant increase in resistance. The apparatus includes a flexible catheter tube that can be inserted into an artery, equipped with a micro-manometer that measures the systemic vascular resistance directly from the blood flow.
Another notable patent involves diagnostic methods and apparatus for monitoring myocardial ischemic events. This invention provides continuous information that can be crucial during various medical procedures, such as balloon angioplasty and anesthesia induction. The method also includes a calibration technique that allows for ongoing calculations of systemic vascular resistance and cardiac output.
Career Highlights
Throughout his career, Raphael Mohr has demonstrated a commitment to advancing medical technology. His innovative approaches have the potential to improve patient outcomes significantly. His work is characterized by a focus on practical applications that address real-world medical challenges.
Collaborations
Mohr has collaborated with notable professionals in his field, including Daniel A Goor and Ihsan A Haddad. These partnerships have likely contributed to the development and refinement of his inventions.
Conclusion
Raphael Mohr's contributions to the detection of myocardial ischemia exemplify the impact of innovation in medical technology. His patents reflect a dedication to improving patient care through advanced monitoring techniques. The significance of his work continues to resonate within the medical community.